Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/23/2010US20100239553 Methods for promoting cellular health and treatment of cancer
09/23/2010US20100239552 Combination Therapies for Treating Metabolic Disorders
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239547 Synthetic hla binding peptide analogues and uses thereof
09/23/2010US20100239534 Hybrid proteins that migrate retrogradely and transynaptically into the CNS
09/23/2010US20100239533 Thraustochytrids, Fatty Acid Compositions, and Methods of Making and Uses Thereof
09/23/2010US20100239527 2,3-substituted azaindole derivatives for treating viral infections
09/23/2010US20100239526 Substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239523 Tlr modulators and methods for using the same
09/23/2010US20100239522 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway
09/23/2010US20100239520 Organic compounds
09/23/2010US20100239518 Ophthalmic composition
09/23/2010US20100239504 Imaging nucleic acid binding proteins
09/23/2010US20100239500 Substituted triazine compounds for nerve regeneration
09/23/2010US20100236562 Inhalable composition
09/23/2010US20100236550 Dry-powder medicament
09/23/2010DE212008000064U1 Vorrichtung zur Überwachung der Diabetes-Insulin-Therapie Apparatus for monitoring the Diabetes Insulin therapy
09/23/2010DE102010001064A1 Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
09/23/2010DE102009014166A1 Product, useful to prevent and treat e.g. acute respiratory diseases such as bronchitis, cough, allergy symptoms and asthma attacks and damages caused by inhalation of atmospheric air pollutants, comprises cobalamin
09/23/2010DE102009014165A1 Product, useful e.g. to treat and prevent disorders or diseases of lungs, cardiovascular and neuronal system caused by inhalation of tobacco smoke and respiratory diseases e.g. asthma, bronchitis and chronic cough, comprises cobalamin
09/23/2010DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof
09/23/2010DE102009013613A1 Trockenverarbeitung von Retigabin Dry processing of retigabine
09/23/2010DE102009013612A1 Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung Retigabine tablets, preferably modified release
09/23/2010DE102009013611A1 Festes Retigabin in nicht-kristalliner Form Solid retigabine in non-crystalline form
09/23/2010CA2835771A1 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
09/23/2010CA2793797A1 Compounds and biological materials and uses thereof
09/23/2010CA2760068A1 Retigabine tablets, preferably with modified release
09/23/2010CA2760043A1 Solid retigabine in non-crystalline form
09/23/2010CA2760040A1 Dry-processing of retigabine
09/23/2010CA2756047A1 Fatty acid monoglyceride compositions
09/23/2010CA2756003A1 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010CA2755975A1 Prenylated bisphosphonates as anti-tuberculosis agents
09/23/2010CA2755969A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010CA2755965A1 Psma-targeting compounds and uses thereof
09/23/2010CA2755828A1 Zoo-technical drug delivery device
09/23/2010CA2755814A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
09/23/2010CA2755808A1 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
09/23/2010CA2755797A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization
09/23/2010CA2755782A1 Biomarkers and uses thereof
09/23/2010CA2755759A1 Substituted pyrimidines for the treatment of cancer
09/23/2010CA2755753A1 Macrocyclic lactone drug delivery system
09/23/2010CA2755738A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
09/23/2010CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010CA2755708A1 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755679A1 Ophthalmic formulations of cetirizine and methods of use
09/23/2010CA2755678A1 Compounds for treating inflammation and pain
09/23/2010CA2755660A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010CA2755641A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010CA2755590A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/23/2010CA2755569A1 Transdermal pharmaceutical preparation and administration of tirofiban
09/23/2010CA2755528A1 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
09/23/2010CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2755251A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010CA2755209A1 Compound for the treatment of tuberculosis
09/23/2010CA2755072A1 Combination therapies for treating metabolic disorders
09/23/2010CA2755069A1 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
09/23/2010CA2754996A1 Ophthalmic formulations of ketotifen and methods of use
09/23/2010CA2754963A1 Use of 2-hidroxyderivates of poliunsaturated fatty acids as medicaments
09/23/2010CA2754605A1 Compounds
09/23/2010CA2754568A1 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
09/23/2010CA2754523A1 3-oxa-7-azabicyclo[3.3.1]nonanes
09/23/2010CA2754509A1 Novel anti-inflammatory agents
09/23/2010CA2754168A1 Fosfluconazole derivatives, synthesis, and use in long acting formulations
09/23/2010CA2753221A1 Pharmaceutical composition comprising aliskiren
09/23/2010CA2749650A1 Piperidine derivatives as nk3 receptor antagonists
09/22/2010EP2230320A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
09/22/2010EP2230317A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
09/22/2010EP2230304A1 RNAI modulation of RSV and therapeutic uses thereof
09/22/2010EP2230258A1 Microbiocide medicament
09/22/2010EP2230243A1 Pharmaceutical compounds
09/22/2010EP2230242A1 Synthesis of new asymmetrically meso-substituted water-soluble porphyrins acting as cytostatic agents
09/22/2010EP2230241A1 Tetrahydro-imidazoý1,5-a¨pyrazine derivatives, preparation methods and medical uses thereof
09/22/2010EP2230240A1 Stable crystal of -lactam compound
09/22/2010EP2230238A2 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
09/22/2010EP2230235A1 Botryosphaerones, novel depsidones and their use as medicaments
09/22/2010EP2230234A1 Process for the preparation of rufinamide
09/22/2010EP2230233A1 1,3-dialkyl-benzimidazole halogenides exhibiting regeneration, anti-inflammatory and antimicrobial activity
09/22/2010EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
09/22/2010EP2230230A1 Substituted dihydroazole compound and pest control agent
09/22/2010EP2229964A1 Stable melt processable chlorhexidine compositions
09/22/2010EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same
09/22/2010EP2229952A1 Plasma anti-diabetic NUCB2 peptide (pladin and nesfatin-1n) and uses thereof
09/22/2010EP2229947A2 Use of biocompatible polymers for the preparation of a medical device or compound
09/22/2010EP2229945A1 Combinations comprising a 4-isoquinolone derivative and anti-HIV agents
09/22/2010EP2229944A1 Preparation composition
09/22/2010EP2229943A1 Compounds for use in the treatment of peripheral neuropathy
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229941A1 Formulations of suberoylanilide hydroxamic acid and methods for producing same
09/22/2010EP2229939A1 Capsule formulation
09/22/2010EP2229938A1 Ezetimibe compositions
09/22/2010EP2229937A1 Dye-free pharmaceutical suspensions comrpising acetaminophen
09/22/2010EP2229936A1 Nanonized testosterone formulations for improved bioavailability
09/22/2010EP2229824A1 Covalent milk protein/isothiocyanate complexes
09/22/2010EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
09/22/2010EP2229443A1 Use of protease nexin 1 inhibitors to reduce metastasis
09/22/2010EP2229442A1 Mcp-i binding nucleic acids and use thereof
09/22/2010EP2229395A1 Substituted sulfonamide derivatives
1 ... 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 ... 7860